Growth Metrics

Nu-Med Plus (NUMD) Free Cash Flow (QoQ) (2012 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Nu-Med Plus - - -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -207.09%
Jun 30, 2024 -414.44%
Mar 31, 2024 89.49%
Dec 31, 2023 77.31%
Sep 30, 2023 18.22%
Jun 30, 2023 -14.41%
Mar 31, 2023 17.46%
Dec 31, 2022 -3,990.61%
Sep 30, 2022 124.75%
Jun 30, 2022 79.10%
Mar 31, 2022 39.81%
Dec 31, 2021 50.81%
Sep 30, 2021 38.30%
Jun 30, 2021 16.16%
Mar 31, 2021 -11.21%
Dec 31, 2020 29.47%
Sep 30, 2020 31.44%
Jun 30, 2020 -54.78%
Mar 31, 2020 23.64%
Dec 31, 2019 -65.20%
Sep 30, 2019 37.39%
Jun 30, 2019 51.15%
Mar 31, 2019 -72.12%
Dec 31, 2018 -0.28%
Sep 30, 2018 -43.57%
Jun 30, 2018 -21.77%
Mar 31, 2018 41.26%
Dec 31, 2017 -8.88%
Sep 30, 2017 -42.68%
Jun 30, 2017 -21.23%
Mar 31, 2017 -79.18%
Dec 31, 2016 -5.90%
Sep 30, 2016 21.81%
Jun 30, 2016 0.90%
Mar 31, 2016 -5.78%
Dec 31, 2015 -20.92%
Sep 30, 2015 25.58%
Jun 30, 2015 -21.97%
Mar 31, 2015 -21.56%
Dec 31, 2014 -0.93%
Sep 30, 2014 16.74%
Jun 30, 2014 3.42%
Mar 31, 2014 -61.08%
Dec 31, 2013 31.75%
Sep 30, 2013 -21.07%
Jun 30, 2013 8.72%
Mar 31, 2013 65.42%
Dec 31, 2012 -290.20%
Sep 30, 2012 28.34%
Jun 30, 2012 -26.49%